ACVRL1 and pulmonary arterial hypertension: Additionally, mutations within the BMPR2 pathway associated with PAH include the type I receptor, activin receptor-like kinase 1 (ALK1), type III receptor accessory protein (endoglin), small mother against decapentaplegic (SMAD) and BMP9 [13].